enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Vildagliptin/metformin - Wikipedia

   en.wikipedia.org/wiki/Vildagliptin/metformin

   Vildagliptin/metformin is indicated in the treatment of type-2 diabetes mellitus: [4] [6] [7] it is indicated in the treatment of adults who are unable to achieve sufficient glycaemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.

3. Vildagliptin - Wikipedia

   en.wikipedia.org/wiki/Vildagliptin

   Vildagliptin, sold under the brand name Galvus and others, is an oral anti-hyperglycemic agent (anti-diabetic drug) of the dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 [2] [3] and GIP [3] by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and ...

4. Dipeptidyl peptidase-4 inhibitor - Wikipedia

   en.wikipedia.org/wiki/Dipeptidyl_peptidase-4...

   Drugs belonging to this class are: Sitagliptin [6] (FDA approved 2006, marketed by Merck & Co. as Januvia) Vildagliptin [7] (EU approved 2007, marketed in the EU by Novartis as Galvus) Saxagliptin (FDA approved in 2009, marketed as Onglyza) Linagliptin (FDA approved in 2011, marketed as Tradjenta by Eli Lilly and Company and Boehringer ...

5. Why Doctors Are Calling This Common Medication a "Wonder Drug"

   www.aol.com/why-doctors-calling-common...

   While it was once “just” a medication for people with type 2 diabetes, metformin is now thought of as a “wonder drug with multiple potentials,” says David Cutler, M.D., a family medicine ...

6. How Much Does Ozempic Cost Without Insurance Compared to ...

   www.aol.com/much-does-ozempic-cost-without...

   Metformin is available as a generic drug, which means it’s generally relatively cheap compared to medications that haven’t yet reached generic status. Here’s a look at how the cost of ...

7. GLP-1 receptor agonist - Wikipedia

   en.wikipedia.org/wiki/GLP-1_receptor_agonist

   GLP-1 agonists were initially developed for type 2 diabetes. [5] The 2022 American Diabetes Association (ADA) standards of medical care in diabetes include GLP-1 agonists or SGLT2 inhibitors as a first-line pharmacological therapy for type 2 diabetes in patients who have or are at high risk for atherosclerotic cardiovascular disease or heart failure.